Search Results

6-OAU 10 mg  | Purity Not Available

TargetMol

6-OAU(GTPL5846; 6-n-octylaminouracil) is a surrogate agonist of GPR84; activates human GPR84 in the presence of Gqi5 chimera in HEK293 cells with an EC50 of 105 nM in the PI assay.

More Information Supplier Page

6-OAU 2 mg  | Purity Not Available

TargetMol

6-OAU(GTPL5846; 6-n-octylaminouracil) is a surrogate agonist of GPR84; activates human GPR84 in the presence of Gqi5 chimera in HEK293 cells with an EC50 of 105 nM in the PI assay.

More Information Supplier Page

6-OAU 5 mg  | Purity Not Available

TargetMol

6-OAU(GTPL5846; 6-n-octylaminouracil) is a surrogate agonist of GPR84; activates human GPR84 in the presence of Gqi5 chimera in HEK293 cells with an EC50 of 105 nM in the PI assay.

More Information Supplier Page

Lumacaftor 100 mg  | 99.72%

TargetMol

VX-809 is a CFTR modulator that corrects the folding and trafficking of CFTR protein. It enhances F508del-CFTR protein maturation in FRT cells (EC50: 100 nM).

More Information Supplier Page

Lumacaftor 10 mg  | 99.72%

TargetMol

VX-809 is a CFTR modulator that corrects the folding and trafficking of CFTR protein. It enhances F508del-CFTR protein maturation in FRT cells (EC50: 100 nM).

More Information Supplier Page

Lumacaftor 50 mg  | 99.72%

TargetMol

VX-809 is a CFTR modulator that corrects the folding and trafficking of CFTR protein. It enhances F508del-CFTR protein maturation in FRT cells (EC50: 100 nM).

More Information Supplier Page

Lumacaftor 5 mg  | 99.72%

TargetMol

VX-809 is a CFTR modulator that corrects the folding and trafficking of CFTR protein. It enhances F508del-CFTR protein maturation in FRT cells (EC50: 100 nM).

More Information Supplier Page

SGC0946 10 mg  | 99.82%

TargetMol

SGC0946 is a highly effective and specific DOT1L methyltransferase inhibitor (IC50: 0.3 nM); selectively kill mixed lineage leukemia cells.

More Information Supplier Page

SGC0946 25 mg  | 99.82%

TargetMol

SGC0946 is a highly effective and specific DOT1L methyltransferase inhibitor (IC50: 0.3 nM); selectively kill mixed lineage leukemia cells.

More Information Supplier Page

SGC0946 2 mg  | 99.82%

TargetMol

SGC0946 is a highly effective and specific DOT1L methyltransferase inhibitor (IC50: 0.3 nM); selectively kill mixed lineage leukemia cells.

More Information Supplier Page